SAMDaily.us | MOD | A | Therapeutic Molecule Phenotypic Screening Capability services in support of USAMRIID

SAMDAILY.US - ISSUE OF SEPTEMBER 17, 2020 SAM #6867
MODIFICATION

A -- Therapeutic Molecule Phenotypic Screening Capability services in support of USAMRIID

Notice Date: 9/15/2020 8:44:32 AM
Notice Type: Justification
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: W4PZ USA MED RSCH ACQUIS ACT FORT DETRICK MD 21702-5014 USA
ZIP Code: 21702-5014
Solicitation Number: W81XWH-20-C-0132
Archive Date: 10/15/2020
Point of Contact: Erik Przygocki, Jayme L. Fletcher
E-Mail Address: erik.j.przygocki.civ@mail.mil, jayme.l.fletcher2.civ@mail.mil
(erik.j.przygocki.civ@mail.mil, jayme.l.fletcher2.civ@mail.mil)
Award Number: W81XWH-20-C-0132
Award Date: 09/14/2020
Description: The Geneva Foundation received a sole source, firm fixed priced award for assay development and therapeutic molecule screening services while in containment.� Refer to attached J&A and Award Notice W81XWH-20-C-0132.
Web Link: SAM.gov Permalink
(https://beta.sam.gov/opp/6ce4ed3a455b49649eb584e8ff505d81/view)
Place of Performance: Address: Frederick, MD 21702, USA; Zip Code: 21702; Country: USA
Record: SN05797469-F 20200917/200915230149 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |